BSEAuro Laboratories LtdHighNeutral
Announced Fri, 29 May · 20:53 IST

Enclosed herewith appointment of Chief Financial Officer, Tax Auditor, Internal Auditor and Reappointment of Cost Auditor.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.0%1-day move
₹280.95
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.0-8.5-9.8-7.5-9.9-9.2-8.5-7.2
Up moveDown movePending
AI summary

Auro Laboratories Limited's Board meeting on May 29, 2026 approved key appointments: Mr. Nitesh Bohra as Chief Financial Officer (replacing the previous CFO), M/s B.L. Dasharda & Associates as Tax Auditors for FY 2026-27, Mr. Kuntal Pancholi as Internal Auditor, and reappointed M/s Poddar & Co. as Cost Auditors. The company also reported strong audited financial results for FY 2025-26 with revenue from operations of Rs 3,074 lakhs, up 58% from Rs 1,940 lakhs in the previous year. Profit after tax more than doubled to Rs 353.29 lakhs from Rs 183.88 lakhs. EPS improved to Rs 5.67 from Rs 2.95. The statutory auditor issued an unmodified (clean) opinion on the financial statements.

Likely market impact

The appointment of a new CFO suggests a potential change in financial leadership, though the company posted strong double-digit growth in revenue and profitability. The clean audit opinion provides positive assurance on financial reporting quality. No immediate negative impact on shareholders expected from these changes.